Sarah Vandenberghe
CRIG member
Lab technician - GMP unit Cell & Gene Therapy (UZ Gent)
Principal investigators: dr. Joline Ingels (PhD) and prof. Bart Vandekerckhove (MD, PhD)
Research focus
CellGENTherapies produces advanced gene-, cell- and tissue-therapeutic products (ATMPs) for early phase clinical trials according to good manufacturing principles (GMP).
We focus on the development and production of small batches of ATMPs or RNA vaccines as required for personalized medicines or phase I studies.
Enabling phase I trials with cell and gene therapy medicinal products
We have experience in the GMP-production of:
- Dendritic cell vaccines
- Lipid nanoparticles containing RNA
- Virus Specific T cells
Contact & links
- Lab address: CellGENTherapies, entrance 71, route 724, Corneel Heymanslaan 10, 9000 Gent
- CellGENTherapies
- Sarah Vandenberghe is interested to receive invitations for presentations or talks